LUGPA helps to promote clinical trials to accelerate recruitment process and provide general information on how LUGPA’s independent urology groups can get involved. LUGPA is in no way involved with these trials, but merely providing a resource hub as a service to its members.  

Clinical Trials Now Enrolling:

Phase 2 Study of TYRA-300 (Dabogratinib) in FGFR3 Altered Low Grade, Intermediate Risk NMIBC

For more clinical trials, please check back later. 

Questions? Please contact Kelsey Brooks at [email protected] or (312) 833-3467.